Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

Dawson HN, Cantillana V, Jansen M, Wang H, Vitek MP, Wilcock DM, Lynch JR, Laskowitz DT.

Neuroscience. 2010 Aug 11;169(1):516-31. doi: 10.1016/j.neuroscience.2010.04.037. Epub 2010 Apr 29.

PMID:
20434528
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.

Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P.

Acta Neuropathol. 2008 Oct;116(4):409-18. doi: 10.1007/s00401-008-0420-0. Epub 2008 Aug 5.

PMID:
18679696
[PubMed - indexed for MEDLINE]
3.

Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.

Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, Pradier L, Brion JP.

Neurobiol Dis. 2004 Feb;15(1):47-60.

PMID:
14751770
[PubMed - indexed for MEDLINE]
4.

Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.

Terwel D, Dewachter I, Van Leuven F.

Neuromolecular Med. 2002;2(2):151-65. Review.

PMID:
12428809
[PubMed - indexed for MEDLINE]
5.

Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

Götz J, Ittner LM, Kins S.

J Neurochem. 2006 Aug;98(4):993-1006. Epub 2006 Jun 19. Review.

PMID:
16787410
[PubMed - indexed for MEDLINE]
6.

Alzheimer's disease and amyloid: culprit or coincidence?

Skaper SD.

Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Review.

PMID:
22748834
[PubMed - indexed for MEDLINE]
7.

Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.

Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA.

Acta Neuropathol. 2006 Apr;111(4):312-9. Epub 2006 Mar 7.

PMID:
16520967
[PubMed - indexed for MEDLINE]
8.

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.

Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D, Van Leuven F.

Exp Gerontol. 2000 Sep;35(6-7):831-41. Review.

PMID:
11053674
[PubMed - indexed for MEDLINE]
9.

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.

Ribé EM, Pérez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sánchez B, Nieto M, Gómez-Ramos P, Morán MA, Cabodevilla F, Samaranch L, Ortiz L, Pérez A, Ferrer I, Avila J, Gómez-Isla T.

Neurobiol Dis. 2005 Dec;20(3):814-22. Epub 2005 Aug 24.

PMID:
16125396
[PubMed - indexed for MEDLINE]
10.

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.

Sanchez-Varo R, Trujillo-Estrada L, Sanchez-Mejias E, Torres M, Baglietto-Vargas D, Moreno-Gonzalez I, De Castro V, Jimenez S, Ruano D, Vizuete M, Davila JC, Garcia-Verdugo JM, Jimenez AJ, Vitorica J, Gutierrez A.

Acta Neuropathol. 2012 Jan;123(1):53-70. doi: 10.1007/s00401-011-0896-x. Epub 2011 Oct 22.

PMID:
22020633
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Age-dependent axonal degeneration in an Alzheimer mouse model.

Wirths O, Weis J, Kayed R, Saido TC, Bayer TA.

Neurobiol Aging. 2007 Nov;28(11):1689-99. Epub 2006 Sep 11.

PMID:
16963164
[PubMed - indexed for MEDLINE]
12.

Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.

Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I.

J Neurosci. 2010 Jul 7;30(27):9228-40. doi: 10.1523/JNEUROSCI.0418-10.2010.

PMID:
20610758
[PubMed - indexed for MEDLINE]
Free Article
13.

Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.

Ferrer I.

Neurotox Res. 2004;6(6):469-75.

PMID:
15658002
[PubMed - indexed for MEDLINE]
14.

Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.

Aso E, Lomoio S, López-González I, Joda L, Carmona M, Fernández-Yagüe N, Moreno J, Juvés S, Pujol A, Pamplona R, Portero-Otin M, Martín V, Díaz M, Ferrer I.

Brain Pathol. 2012 Sep;22(5):636-53. doi: 10.1111/j.1750-3639.2011.00560.x. Epub 2012 Jan 13.

PMID:
22188425
[PubMed - indexed for MEDLINE]
15.

Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.

Saul A, Sprenger F, Bayer TA, Wirths O.

Neurobiol Aging. 2013 Nov;34(11):2564-73. doi: 10.1016/j.neurobiolaging.2013.05.003. Epub 2013 Jun 5.

PMID:
23747045
[PubMed - indexed for MEDLINE]
16.

Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.

Götz J, Schild A, Hoerndli F, Pennanen L.

Int J Dev Neurosci. 2004 Nov;22(7):453-65. Review.

PMID:
15465275
[PubMed - indexed for MEDLINE]
17.

Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice.

Masliah E, Xie F, Dayan S, Rockenstein E, Mante M, Adame A, Patrick CM, Chan AF, Zheng B.

Neuroscience. 2010 Aug 11;169(1):488-94. doi: 10.1016/j.neuroscience.2010.04.045. Epub 2010 Apr 28.

PMID:
20433905
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.

Paulson JB, Ramsden M, Forster C, Sherman MA, McGowan E, Ashe KH.

Am J Pathol. 2008 Sep;173(3):762-72. doi: 10.2353/ajpath.2008.080175. Epub 2008 Jul 31.

PMID:
18669616
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.

Samura E, Shoji M, Kawarabayashi T, Sasaki A, Matsubara E, Murakami T, Wuhua X, Tamura S, Ikeda M, Ishiguro K, Saido TC, Westaway D, St George Hyslop P, Harigaya Y, Abe K.

Brain Res. 2006 Jun 13;1094(1):192-9. Epub 2006 May 19.

PMID:
16713590
[PubMed - indexed for MEDLINE]
20.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk